US 8404810
Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma
granted A61KA61K38/00
Quick answer
US patent 8404810 (Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma) held by Five Prime Therapeutics, Inc. expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00